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Bacterial isolates, antimicrobial susceptibility patterns, and factors
associated with infection and outcome in foals with septic arthritis: 83
cases (1998–2013)
Abstract
Objective—To determine clinical characteristics, clinicopathologic data, and bacterial culture and
antimicrobial susceptibility results associated with septic arthritis in foals ≤ 180 days old.
Design—Retrospective case series.
Animals—83 foals with septic arthritis.
Procedures—Medical records at 2 teaching hospitals between 1998 and 2013 were searched to identify those
for foals ≤ 180 days old with confirmed infection of ≥ 1 synovial structure. Data extracted from the records
included signalment, clinicopathologic information, bacteriologic culture and antimicrobial susceptibility
results, and outcome. Data were analyzed for all foals as a single population and for foals stratified into 3 age
groups (≤ 7 days, 8 to 30 days, and 31 to 180 days).
Results—Mean ± SD age of all foals was 18.2 ± 25 days (range, 0 to 180 days). The median number of joints
affected per foal was 2 (range, 1 to 10 joints). Forty-seven of 83 (56.6%) foals survived to discharge from the
hospital. Seventy antemortem synovial fluid samples underwent bacteriologic culture, of which 60 (85.7%)
yielded growth. Of the 72 bacterial isolates identified, 45 (62.5%) were gram negative and 27 (375%) were
gram positive. Survival rate was positively associated with plasma fibrinogen concentration and negatively
associated with number of affected joints.
Conclusions and Clinical Relevance—Results indicated the frequency with which certain bacterial agents
were isolated from septic joints, which may be beneficial for the empirical treatment of septic arthritis in foals.
Also, the positive association between survival rate and plasma fibrinogen concentration may have prognostic
value in a clinical setting.
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Septic arthritis is a common complication of sepsis in foals and results in prolonged treatment and sub-
stantial medical expense and is associated with a poor 
prognosis.1,2 In neonatal foals, septic arthritis is most 
commonly caused by hematogenous dissemination of 
bacteria, but extension of an infection from adjacent 
infected soft tissues or penetrating wounds or infection 
by iatrogenic routes is also possible.1,3 In older foals 
(> 7 days old), septic arthritis can be caused by vari-
ous bacteria. Older foals are particularly susceptible to 
infection with Rhodococcus equi, which can cause extra-
pulmonary disorders. In 1 study,4 14 of 150 (9%) foals 
> 30 days old with confirmed R equi infection devel-
oped septic arthritis. Rates of survival to discharge for 
foals admitted to various veterinary hospitals for treat-
ment of septic arthritis range from 45% to 84%.2,5,6 
Foals that recover from septic arthritis are at increased 
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risk of developing degenerative joint disease that will 
impair athletic performance, compared with foals that 
did not have septic arthritis.6,7
Although foals with septic arthritis may have no 
overt signs of systemic illness, foals with lameness or 
joint effusion are considered to have infectious ortho-
pedic disease until proven otherwise.8,9 Early identifica-
tion and treatment improve the odds for a successful 
outcome in foals with septic arthritis.1 Foals with septic 
arthritis are routinely treated empirically with antimi-
crobials on the basis of the attending veterinarian’s sus-
picion of the causative agent while awaiting the results 
of bacteriologic culture of synovial fluid samples and 
antimicrobial susceptibility testing. Because synovial 
infection in foals is generally the result of hematoge-
nous bacterial dissemination, bacteria associated with 
bacteremia would presumably be the most common 
bacterial isolates from infected joints. In a 1989 retro-
spective study10 of 47 foals < 8 days old with bacterial 
septicemia, gram-negative bacteria were isolated from 
all foals. However in subsequent studies11,12 of critically 
ill foals < 1 month old, the percentage of foals from 
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Warren, Wong) and Veterinary Diagnostic and Production Animal 
Medicine (Wang), College of Veterinary Medicine, and the Depart-
ment of Statistics, College of Liberal Arts and Sciences (Sun), Iowa 
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ABBREVIATION
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which gram-negative bacteria were isolated from blood 
samples ranged from 57% to 66%, whereas the percent-
age of foals from which gram-positive bacteria were 
isolated from blood samples ranged from 34% to 40%. 
Gram-negative bacteria such as Escherichia coli, Actino-
bacillus spp, and Klebsiella spp are more commonly iso-
lated from the joints of foals with septic arthritis than 
are gram-positive bacteria such as Staphylococcus spp 
and Streptococcus spp.3,5 However, in 1 study,2 gram-
positive bacteria (26/34 [76%]) were isolated more fre-
quently than were gram-negative bacteria (8/34 [24%]) 
from the joints of foals with septic arthritis. Differences 
in the ages of the foals evaluated in those studies2,3,5 
may account for the apparently conflicting results be-
cause, in foals, infections caused by gram-negative bac-
teria develop most frequently in the neonatal period, 
whereas infections caused by gram-positive bacteria 
generally occur after the neonatal period.1
Although studies9,13 have been conducted to assess 
variables associated with bacterial isolates from adult horses 
with infectious orthopedic disease and foals with osteomy-
elitis, to our knowledge, studies to identify variables associ-
ated with septic arthritis in foals or evaluate the compre-
hensive antimicrobial susceptibility patterns for the bacteria 
that commonly cause septic arthritis in foals have not been 
performed. Information, including the antimicrobial sus-
ceptibility results, for bacterial pathogens commonly iso-
lated from the joints of foals with septic arthritis and the age 
at which infections caused by a specific bacterium generally 
occur would help clinicians develop empirical treatment 
protocols for such foals. The objective of the study reported 
here was to determine the clinical characteristics, clinico-
pathologic data, and bacteriologic culture and antimicrobial 
susceptibility results associated with septic arthritis in foals 
of 3 age groups (≤ 7 days, 8 to 30 days, and 31 to 180 days).
Materials and Methods
Case selection—The medical record databases of the 
Lloyd Veterinary Medical Center at Iowa State University 
and the Purdue University Veterinary Teaching Hospital 
were searched for records of foals ≤ 180 days old that 
were treated for septic arthritis between January 1998 
and September 2013. Foals were included in the study if 
septic arthritis was definitively diagnosed on the basis of 
the currently recommended criteria.1,3 Briefly, each foal 
had to have ≥ 1 of the following: bacterial growth from 
culture of a synovial fluid sample or biopsy specimen, 
synovial fluid TNCC ≥ 30,000 cells/µL, or the presence 
of suppurative or fibrinous inflammation within a joint 
during postmortem examination. Foals that were treated 
for septic arthritis on the basis of a high index of suspi-
cion that did not meet the inclusion criteria or that had a 
history of trauma or other orthopedic conditions such as 
flexural or angular limb deformities and fractures were 
excluded from the study. Presumptive history from the 
owner that the mare stepped on the foal was not consid-
ered cause for exclusion from the study.
Medical records review—Only data that contrib-
uted to the diagnosis of septic arthritis were analyzed 
for each foal. Information extracted from each medical 
record included the foal’s age, breed, sex, WBC count, 
segmented and band neutrophil counts, plasma fibrino-
gen concentration (determined by heat precipitation), 
synovial fluid TNCC and protein concentration, bac-
teriologic culture results of blood (if performed) and 
synovial samples, the number of affected joints, and 
whether the foal survived to discharge from the hos-
pital. For samples from which bacteria were cultured, 
antimicrobial susceptibility results were also recorded.
Bacterial culture and susceptibility testing—For 
foals treated at Iowa State University, all synovial fluid 
samples were cultured directly on aerobic blood agar, 
MacConkey agar, anaerobic blood agar, and Columbia 
nalidixic acid agar; 50 to 100 µL of each sample was in-
oculated onto each agar plate. Additionally, 0.5 mL of 
each sample was added to 5 mL of brain-heart infusion 
broth for enrichment. In vitro antimicrobial susceptibil-
ity testing was performed with the Kirby-Bauer disk dif-
fusion method until 2008 and a diagnostic microbiology 
systema thereafter.
For foals treated at Purdue University, 10 µL of 
each synovial fluid sample was inoculated onto a blood 
agar plate and a MacConkey agar plate. Enrichment was 
only performed on request, and information regarding 
which samples were enriched was not available. When 
performed, enrichment included inoculation of a tube 
of thioglycollate broth with 10 µL of synovial fluid, 
incubation for 7 days, and subculturing if growth was 
present. In vitro antimicrobial susceptibility testing was 
performed with a diagnostic microbiology system,a and 
the minimum inhibitory concentration for each isolate 
and antimicrobial combination was determined by a 
broth microdilution method in accordance with the Na-
tional Accrediting Agency for Clinical Laboratory Sci-
ences and Clinical and Laboratory Standards Institute 
guidelines.
For summary purposes, bacterial isolates were cat-
egorized as susceptible, intermediate, or resistant to 
individual antimicrobials. Isolates classified as suscep-
tible were those that are inhibited by the usually achiev-
able concentration of the antimicrobial under consid-
eration when it is administered at the recommended 
dose for the site of infection. Isolates for which the 
minimum inhibitory concentration of the antimicro-
bial under consideration approached usually attainable 
concentrations in the target tissue following adminis-
tration of the recommended dose, but for which the 
response rate might be lower than that for susceptible 
isolates were classified as intermediate. Isolates classi-
fied as resistant were those that were not inhibited by 
the usually achievable concentration of the antimicro-
bial under consideration when it is administered at the 
recommended dose for the target tissue.
Statistical analysis—For analysis purposes, all 
foals were assessed as a single population and then cat-
egorized by age into 3 groups (≤ 7 days old, 8 to 30 
days old, and 31 to 180 days old). The ≤ 7 days old cat-
egory was selected because bacteremia and septicemia 
are the most important risk factors for septic arthritis 
in neonatal foals and foals with confirmed sepsis are 
most commonly ≤ 7 days old.1,14–16 The 8 to 30 days 
old category was selected because foals are at less risk 
of developing sepsis during this period, compared with 
the period from birth to ≤ 7 days old.15,16 The 31 to 180 
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days old category was selected because septic arthritis 
caused by R equi most commonly occurs during this 
period.17,18 No differentiation was made between foals 
that died and those that were euthanized, regardless of 
reason.
Outcomes of interest included the number of joints 
affected, WBC count, segmented and band neutrophil 
counts, plasma fibrinogen concentration, synovial fluid 
TNCC and protein concentration, bacteriologic culture 
and antimicrobial susceptibility results, and short-term 
survival rate (ie, survival to hospital discharge). Descrip-
tive data were provided. The respective associations 
between age and each of the categorical variables were 
assessed by means of Fisher exact tests. Linear models 
were used to identify variables associated with each of 
the quantitative outcomes of interest. Prior to analysis, 
a logarithmic transformation was applied to the data 
for WBC count, segmented neutrophil count, plasma 
fibrinogen concentration, and synovial fluid TNCC 
to account for multiplicative variation in the distribu-
tions of those variables. Data for the band neutrophil 
count and the number of joints affected were analyzed 
by means of Wilcoxon score–based nonparametric tests 
(Wilcoxon 2-sample rank sum tests or Kruskal-Wallis 
multiple-sample tests) because they did not have nor-
mal distributions, even after transformation. Logistic 
regression was used to assess the association of various 
explanatory variables with survival to discharge (yes or 
no). Mixed models with a random effect for foal were 
used when necessary to account for repeated measures 
within the same animal. Post hoc pairwise comparisons 
were performed by means of Tukey t tests (for F tests in 
linear models) or Bonferroni-adjusted Wilcoxon rank 
sum tests (for nonparametric Kruskal-Wallis tests). 
Analyses were performed with statistical software,b and 
values of P ≤ 0.05 were considered significant.
Results
Foals—During the study period, 5,552 foals 
(3,992 from Iowa State University and 1,560 from 
Purdue University) ≤ 180 days old were examined, 
of which 83 were eligible for inclusion in the study. 
The study population included 36 male and 47 female 
foals. The mean ± SD age of all foals was 18.2 ± 25 
days (range, < 1 to 180 days old); 5 foals were < 24 
hours old at the time of hospital admission. At the 
time of admission, 34 foals were ≤ 7 days old, 36 were 
between 8 and 30 days old, and 13 were between 31 
and 180 days old. Breeds represented included Quar-
ter Horse (n = 33), Thoroughbred (11), Paint (10), 
Standardbred (7), Miniature (4), Percheron (3), Ara-
bian (2), Belgian (2), Saddlebred (2), and Appaloosa, 
Clydesdale, Haflinger, Lusitano, Oldenburg, Pony of 
the Americas, Tennessee Walking Horse, warmblood, 
and mixed breed (1 each). The clinicopathologic vari-
ables for the foals were summarized (Table 1). The 
mean WBC count, segmented neutrophil count, and 
plasma fibrinogen concentration for foals ≤ 7 days old 
were significantly (P < 0.001) lower, compared with 
the corresponding values for foals between 8 and 30 
days old and foals between 31 and 180 days old. The 
mean band neutrophil count and synovial fluid TNCC 
and protein concentration did not differ significantly 
among the age groups.
Affected joints—The study population had 196 af-
fected synovial structures, with the tarsal joint being 
the structure most frequently affected (Table 2). Thirty-
eight foals had 1 joint affected; 18 foals had 2 joints af-
fected; 10 foals had 3 joints affected; 4 foals had 4 joints 
affected; 5 foals had 5 joints affected; 2 foals each had 
6, 7, and 8 joints affected; and 1 foal had 10 joints af-
fected. The number of joints affected for 1 foal was not 
available. The median number of joints affected per foal 
for foals between 31 and 180 days old was significantly 
(P = 0.002) less than that for foals ≤ 7 days old and foals 
between 8 and 30 days old.
Bacteriologic culture and antimicrobial suscepti-
bility testing—One hundred seventeen synovial fluid 
samples were obtained for cytologic analysis or bacte-
riologic culture. Of the 70 antemortem synovial fluid 
samples that underwent bacteriologic culture, growth 
was detected in 60 (85.7%) samples and no growth was 
detected in 10 (14.3%) samples. Seventy-two bacte-
 Age category 
Variable All foals ≤ 7 days old 8–30 days old 31–180 days old
No. of foals 83 34 36 13
Age (d) 18.2 ± 25 2 (0–7) 17 (7–30) 49 (31–180)
WBC count (cells/µL) 15,786 ± 31,208 6,700 (636–20,900)a 14,905 (2,080–281,000)b 12,800 (5,380–45,600)b
Segmented neutrophil count (cells/µL) 20,600 ± 7,918 4,869 (90–34,275)a 12,618 (1,120–33,750)b 9,728 (2,860–38,760)b
Band neutrophil count (cells/µL) 432 ± 878 90 (0–3,410) 0 (0–5,360) 0 (0–1,290)
Fibrinogen (mg/dL) 578 ± 257 400 (155–1,200)a 600 (149–1,200)b 616 (412–1,100)b
Synovial fluid TNCC (cells/µL) 68,718 ± 74,276 31,500 (1,500–86,786) 63,490 (560–343,000) 37,015 (5,760–93,880)
Synovial fluid protein (g/dL) 3.9 ±1.2 3.4 (2.2–7.5) 3.7 (2.5–5.6) 3.7 (2.7–5.3)
No. of gram-positive isolates 18 7 7 4
No. of gram-negative isolates 37 16 17 4
No. (%) of foals that survived to discharge 47 (56.6) 16 (47)  22 (61)  9 (69)
Values in the all foals column represent the mean ± SD, and those in the other columns represent the median (range) unless otherwise 
indicated.
a,bWithin a row, values with different superscripts differ significantly (P < 0.05).
To be included in the study, each foal had to have ≥ 1 of the following: bacterial growth from culture of a synovial fluid sample or biopsy speci-
men, synovial fluid TNCC ≥ 30,000 cells/µL, or the presence of suppurative or fibrinous inflammation within a joint during postmortem examination.
Table 1—Clinicopathologic variables for 83 foals with septic arthritis that were treated at 2 veterinary teaching hospitals between Janu-
ary 1998 and September 2013.
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rial isolates were identified, of which 45 (62.5%) were 
gram-negative organisms and 27 (37.5%) were gram-
positive organisms (Table 3). One bacterial isolate was 
cultured from each of 53 samples, 2 bacterial isolates 
were cultured from each of 7 samples, and 3 bacterial 
isolates were cultured from 1 sample. The number of 
gram-positive or gram-negative organisms cultured did 
not differ significantly among the 3 age groups. Infec-
tion with a gram-positive or gram-negative organism 
was not significantly associated with the WBC count, 
synovial fluid TNCC or protein concentration, number 
of joints affected per foal, or survival to hospital dis-
charge. Results of antimicrobial susceptibility testing 
were summarized (Table 4).
Blood samples from 19 foals (age, < 1 to 21 days) were 
submitted for bacteriologic culture. Bacterial growth was de-
tected in 13 of those samples, and 20 isolates were identified 
(data not shown). For foals that had bacteriologic cultures per-
formed on both blood and synovial fluid samples that yielded 
growth, the same bacterial isolate was identified in both sam-
ples for 6 foals (A equuli [n = 2 foals], Klebsiella spp [2], Salmo-
nella spp [1], and Morganella morganii [1]), whereas the bacte-
ria isolated from the blood differed from that isolated from the 
synovial fluid for 7 foals. Rhodococcus equi was isolated from 
synovial samples from only 3 foals in the 31 to 180 days old 
group; those foals were 49, 61, and 74 days old when admitted 
to the hospital. Survival to discharge was not associated with 
positive results on bacteriologic culture of blood.
   Age group 
   8–30 31–180
Synovial structure All foals ≤ 7 days old days old days old
Tarsal joint 76 (38.8) 40 (44.4) 33 (35.5) 3 (23.1)
Metacarpophalangeal or metatarsophalangeal joint 31 (15.8) 17 (18.9) 11 (11.8) 3 (23.1)
Stifle joint 41 (20.9) 14 (15.6) 20 (21.5) 7 (53.8)
Carpal joint 24 (12.2) 11 (12.2) 13 (14.0) 0 (0.0)
Proximal interphalangeal joint 5 (2.6) 3 (3.3) 2 (2.2) 0 (0.0)
Distal interphalangeal joint 1 (0.5) 1 (1.1) 0 (0.0) 0 (0.0)
Hip joint 3 (1.5) 1 (1.1) 2 (2.2) 0 (0.0)
Shoulder joint 5 (2.6) 0 (0.0) 5 (5.4) 0 (0.0)
Elbow joint 4 (2.0) 0 (0.0) 4 (4.3) 0 (0.0)
Tendon sheath 5 (2.6) 2 (2.2) 3 (3.2) 0 (0.0)
Unidentified or unavailable in medical record 1 (0.5) 1 (1.1) 0 (0.0) 0 (0.0)
Total No. of structures affected   196  90  93  13
Median (range) No. of structures affected/foal 2 (1–10) 2 (1–8)a 1.5 (1–10)a 1 (1–2)b
Values represent the No. (%) unless otherwise indicated.
Within a column, percentages may not sum to 100 because of rounding.
See Table 1 for remainder of key.
Table 2—Frequency distribution of infected synovial structures for the foals of Table 1.
Gram stain
result Category Isolate No. (%)
Gram negative Enterobacteriaceae Escherichia coli 13 (18.1)
  Proteus spp 1 (1.4)
  Enterobacter aerogenes  2 (2.8)
  Enterobacter cloacae 2 (2.8)
  Unspeciated Enterobacter spp 2 (2.8)
  Klebsiella pneumoniae 2 (2.8)
  Klebsiella oxytoca 4 (5.6)
  Salmonella enterica serovar Typhimurium 1 (1.4)
  Unspeciated salmonellae 2 (2.8)
  Morganella morganii 1 (1.4)
  Raoultella planticola 1 (1.4)
 Other gram-negative isolates Actinobacillus equuli 9 (12.5)
  Actinobacillus suis  2 (2.8)
  Pasteurella multocida 1 (1.4)
  Bacteroides fragilis 1 (1.4)
  Chryseobacterium meningosepticum 1 (1.4)
Gram positive Coagulase-negative staphylococci Staphylococcus epidermidis 6 (8.3)
  Unspeciated staphylococci 2 (2.8)
 Streptococci α-Hemolytic streptococci 5 (6.9)
  Unspeciated β-hemolytic streptococci 1 (1.4)
  Streptococcus zooepidemicus 4 (5.6)
 Other gram-positive isolates Enterococcus spp 3 (4.2)
  Rhodococcus equi 3 (4.2)
  Clostridium perfringens 1 (1.4)
  Corynebacterium spp 1 (1.4)
  Micrococcus spp 1 (1.4)
Percentages do not sum to 100% because of rounding.
See Table 1 for remainder of key.
Table 3—Frequency distribution of 72 bacterial isolates cultured from the infected synovial structures 
of the foals of Table 1.
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Survival analysis—Forty-seven of 83 (56.6%) foals 
survived to discharge, and the proportion of foals that 
survived to discharge did not differ significantly among 
the 3 age groups (Table 1). The medians of various vari-
ables for foals that did and did not survive to discharge 
were summarized (Table 5). Survival to discharge was 
not associated with the WBC count, segmented or band 
neutrophil count, synovial fluid TNCC or protein con-
centration, or type of infection (gram negative vs gram 
positive). Survival to discharge was positively associ-
ated with plasma fibrinogen concentration (P = 0.014) 
and negatively associated with the number of joints af-
fected (P < 0.001). When the model was adjusted for 
the effect of age, the positive association between sur-
vival to discharge and plasma fibrinogen concentration 
remained significant (P = 0.05). The probability that a 
foal survived to hospital discharge increased 25% (OR, 
1.25; 95% confidence interval, 1.03 to 1.55) for every 
100 mg/dL increase in plasma fibrinogen concentra-
tion. Conversely, the probability that a foal survived to 
 Foals that survived Foals that did
Variable to discharge not survive P value
Age (d) 12 (0–180) 7 (0–90) 0.33
WBC count (cells/µL) 12,735 (2,540–281,100) 10,915 (636–35,900) 0.26
Segmented neutrophil count (cells/µL) 9,332 (430–38,760) 8,780 (90–33,750) 0.18
Band neutrophil count (cells/µL) 0 (0–3410) 80 (0–5,360) 0.42
Fibrinogen (mg/dL) 600 (200–1200) 465 (149–1200) 0.01
Synovial fluid TNCC (cells/µL) 49,250 (560–343,000) 19,200 (1,500–114,000) 0.17
Synovial fluid protein (g/dL) 3.7 (2.2–6.4) 3.7 (2.4–7.5) 0.95
No. of joints affected 1 (1–8) 3 (1–10) < 0.001
See Table 1 for key.
Table 5—Median (range) values for various variables of the foals of Table 1 that did (n = 47) and did not 
(36) survive to hospital discharge.
 Gram-negative isolates Gram-positive isolates 
Antimicrobial Susceptible Intermediate Resistant Susceptible Intermediate Resistant
Amikacin 28 (82.4) 1 (2.9) 5 (14.7) 12 (57.1) 2 (9.5) 7 (33.3)
Amoxicillin–clavulanic acid 7 (58.3) 1 (8.3) 4 (33.3) 8 (80.0) 0 (0) 2 (20.0)
Cefazolin 19 (55.9) 0 (0) 15 (44.1) 13 (61.9) 3 (14.3) 5 (23.8)
Cefotaxime 11 (61.1) 0 (0) 7 (38.9) 9 (64.3) 0 (0) 5 (35.7)
Cefoxitin 5 (100) 0 (0) 0 (0) 3 (60.0) 0 (0) 2 (40.0)
Cefpodoxime 8 (61.5) 1 (7.7) 4 (30.8) 7 (70.0) 1 (10.0) 2 (20.0)
Ceftazidime 5 (71.4) 0 (0) 2 (28.6) 1 (33.3) 1 (33.3) 1 (33.3)
Ceftiofur 4 (57.1) 0 (0) 3 (42.9) 3 (75.0) 0 (0) 1 (25.0)
Cephalothin 25 (75.8) 1 (3.0) 7 (21.2) 14 (66.7) 0 (0) 7 (33.3)
Ciprofloxacin 16 (57.1) 4 (14.3) 8 (28.6) 11 (64.7) 1 (5.9) 5 (29.4)
Clindamycin 5 (71.4) 0 (0) 2 (28.6) 7 (100.0) 0 (0) 0 (0)
Chloramphenicol 0 (0) 2 (7.1) 26 (92.9) 8 (47.1) 3 (17.6) 6 (35.3)
Doxycycline 12 (63.2) 2 (10.5) 5 (26.3) 13 (92.9) 0 (0) 1 (7.1)
Enrofloxacin 3 (42.9) 0 (0) 4 (57.1) 2 (50.0) 1 (25.0) 1 (25.0)
Erythromycin 28 (93.3) 0 (0) 2 (6.7) 16 (80.0) 4 (20.0) 0 (0)
Gentamicin 4 (11.8) 9 (26.5) 21 (61.8) 10 (47.6) 6 (28.6) 5 (23.8)
Imipenem 26 (76.5) 2 (5.9) 6 (17.6) 14 (66.7) 2 (9.5) 5 (23.8)
Marbofloxacin 13 (92.9) 0 (0) 1 (7.1) 7 (100.0) 0 (0) 0 (0)
Neomycin 7 (100) 0 (0) 0 (0) 2 (100.0) 0 (0) 0 (0)
Orbifloxacin 9 (56.3) 4 (25.0) 3 (18.8) 5 (71.4) 0 (0) 4 (28.6)
Ormetroprim-sulfadimethoxine 7 (100) 0 (0) 0 (0) — — —
Oracillin 2% NaCl 3 (60.0) 0 (0) 2 (40.0) 5 (71.4) 2 (28.6) 0 (0)
Penicillin 5 (18.5) 0 (0) 22 (81.5) 11 (64.7) 0 (0) 6 (35.3)
Rifampin 2 (5.9) 3 (8.8) 29 (85.3) 9 (42.9) 1 (4.8) 8 (38.1)
Sulfachloropyridazine 10 (31.3) 2 (6.3) 20 (62.5) 20 (95.2) 1 (4.8) 0 (0)
Tetracycline 13 (81.3) 0 (0) 3 (18.8) 4 (57.1) 1 (14.3) 2 (28.6)
Ticarcillin 23 (69.7) 1 (3.0) 9 (27.3) 11 (52.4) 3 (14.3) 7 (33.3)
Ticarcillin–clavulanic acid 19 (57.6) 1 (3.0) 13 (39.4) 15 (71.4) 1 (4.8) 5 (23.8)
Trimethoprim-sulfa 18 (69.2) 4 (15.4) 4 (15.4) 12 (85.7) 0 (0) 2 (14.3)
Vancomycin 25 (73.5) 0 (0) 9 (26.5) 17 (81.0) 1 (4.8) 3 (14.3)
— = Not assessed.
The antimicrobials included in the susceptibility test varied among bacterial isolates; therefore, the number of isolates classified within each 
antimicrobial varies. The percentage of isolates within each classification represents the percentage for gram-negative or gram-positive isolates. 
Isolates classified as susceptible were those that are inhibited by the usually achievable concentration of the antimicrobial under consideration 
when it is administered at the recommended dose for the site of infection. Isolates for which the minimum inhibitory concentration of the antimi-
crobial under consideration approached usually attainable concentrations in the target tissue following administration of the recommended dose, 
but for which the response rate might be lower than that for susceptible isolates were classified as intermediate. Isolates classified as resistant 
were those that were not inhibited by the usually achievable concentration of the antimicrobial under consideration when it is administered at the 
recommended dose for the target tissue.
See Table 1 for remainder of key.
Table 4—Number (%) of bacterial isolates cultured from the synovial structures of the foals of Table 1 that were classified as suscep-
tible, intermediate, or resistant to various antimicrobials.
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hospital discharge decreased by 50% (OR, 0.50; 95% 
confidence interval, 0.33 to 0.71) for every additional 
joint that was affected. The probability of survival to 
discharge did not differ between foals that were treated 
at Iowa State University and those treated at Purdue 
University, nor did it differ by year during the study 
period.
Discussion
Similar to human infants, foals are more suscep-
tible to hematogenous infection of synovial structures 
than are adult horses because they have transphyseal 
vessels that can transport bacteria into joints, whereas 
adult horses and humans have separate blood supplies 
to the metaphysis and epiphysis.1,19 Foals with septic 
arthritis are frequently encountered in clinical settings 
and the disease can have devastating consequences 
on the future athletic performance of affected horses. 
Thus, the presence and severity of septic arthritis have 
a substantial impact on decisions regarding the treat-
ment or euthanasia of affected foals. Musculoskel-
etal disease, including septic arthritis, was the most 
common cause of death in a survey20 of 2,468 foals 
from 167 farms, and results of another study21 indi-
cate a significant association between septic arthritis 
and death in bacteremic foals. In the present study, a 
number of important findings regarding septic arthri-
tis were identified that might facilitate its diagnosis 
and treatment and aid in determining the short-term 
prognoses for affected foals.
In the foals of the present study, gram-negative 
bacteria were isolated from affected joints more fre-
quently than were gram-positive bacteria, a finding 
that was similar to the results of most other studies in 
the literature, although in 1 study,2 gram-positive bac-
teria were isolated more frequently than were gram-
negative bacteria from the joints of foals with septic 
arthritis. Staphylococcus spp are the bacteria most fre-
quently isolated from the joints of children with sep-
tic arthritis22,23 and adult horses with septic arthritis 
secondary to intra-articular injections, penetrating 
wounds, idiopathic infections, and surgical proce-
dures.5 The different routes by which joints generally 
become infected in foals (hematogenous) versus adult 
horses (direct inoculation) likely contribute to the 
difference in the types of bacteria (gram negative vs 
gram positive) isolated from those joints. In the pres-
ent study, age was not significantly associated with the 
isolation of either gram-negative or gram-positive or-
ganisms from the infected joint; however, results of 
another study20 indicate that gram-negative bactere-
mia and sepsis were more prevalent in younger foals 
than in older foals. Enterobacteriaceae are commonly 
isolated from bacteriologic cultures of blood, and 
E coli is the most common cause of bacteremia in neo-
natal foals.21,24 Given that the joints of foals are gen-
erally infected by the hematogenous route, it is not 
surprising that E coli was the most common gram-
negative bacteria isolated from the septic joints of the 
foals in the present study as well as other studies.2,3,7 
Thirty-one of 45 (69%) gram-negative organisms iso-
lated from the joints of the foals of the present study 
belonged to the family Enterobacteriaceae, which 
highlights the importance and frequency of involve-
ment of this bacterial family in the development of 
septic arthritis. Therefore, clinicians should select an-
timicrobials that are effective against Enterobacteria-
ceae for the empirical treatment of foals with septic ar-
thritis. Interestingly, 13 foals of the present study had 
bacteria cultured from a blood sample; however, in the 
majority (n = 7) of those foals, the bacteria isolated 
from the blood sample differed from that isolated from 
the synovial fluid sample. This finding suggested that 
it is important to perform bacteriologic culture of both 
blood and synovial fluid in overtly ill foals.
Definitive diagnosis of septic arthritis can be diffi-
cult because of the lack of established diagnostic criteria 
for synovial fluid variables, the low number of bacteria 
frequently cultured from infected synovial structures, 
and nonspecific changes in hematologic and biochemi-
cal analyses.1–3,6,7,21 Consequently, a variety of diagnos-
tic criteria have been used to diagnose septic arthritis 
in foals, which has inevitably led to discrepancies in the 
estimates of its true prevalence.1–3,7 The cutoffs used as 
criteria to diagnose septic arthritis range from 5,000 to 
30,000 cells/µL for synovial fluid TNCC and 2.5 to 4 g/
dL for synovial fluid protein concentration.1–3,7,25 In a 
study26 in which synovial fluid changes were compared 
among healthy horses and horses with osteochondri-
tis dissecans, traumatic noninfectious synovitis, and 
infectious synovitis, the highest mean synovial fluid 
neutrophil count (380 X 103 neutrophils/µL) and pro-
tein concentration (6.2 g/dL) were observed for horses 
with infectious synovitis, although the ranges for those 
variables overlapped considerably with the ranges of 
the corresponding variables for horses with traumatic 
noninfectious synovitis. In another study,5 the mean sy-
novial WBC count was 76.49 X 103 WBCs/µL for 192 
horses with septic arthritis or tenosynovitis. Although 
the clinical tendency may be to assume a positive as-
sociation between severity of disease and synovial fluid 
TNCC or protein concentration, this assumption has 
yet to be validated.2,5 Survival was not significantly as-
sociated with either synovial fluid TNCC or protein 
concentration in the present study or another study2 of 
81 foals with septic arthritis. In the study5 of horses 
with septic arthritis or tenosynovitis, the proportion 
(30/66 [45%]) of foals < 6 months that survived was 
significantly lower than the proportion of adult horses 
that survived (107/126 [85%]); however, the synovial 
fluid TNCC did not differ significantly between foals 
and adult horses.
Although culture of bacteria from synovial fluid 
provides a definitive diagnosis of septic arthritis, the 
proportion of synovial fluid samples from foals with 
septic arthritis that yielded bacterial growth ranged 
from 45% to 78% in other studies.1–3,7,27 Bacteria were 
isolated from 60 of the 70 (86%) synovial fluid sam-
ples that were submitted for bacteriologic culture in 
the present study. It is possible that the strict inclusion 
criteria used for the foals in this study contributed to 
the higher proportion of culture-positive synovial flu-
id samples, compared with that of other studies.1–3,7,27 
Interestingly, bacteriologic culture of a synovial bi-
opsy specimen is even less rewarding than bacterio-
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logic culture of a synovial fluid sample. In a study27 of 
64 horses with suspected infectious arthritis, bacteria 
were isolated from 52% of synovial fluid samples and 
only 36% of synovial membrane biopsy specimens. Of 
the 17 horses that had bacteriologic culture performed 
on both a synovial fluid sample and synovial mem-
brane biopsy specimen in that study,27 16 had positive 
results for the synovial fluid sample, whereas only 1 
had positive results for the synovial membrane biopsy 
specimen. In a study28 that involved dogs with experi-
mentally induced septic arthritis, bacteria were cul-
tured from 8 of 9 synovial fluid samples but only 6 of 
9 synovial membrane specimens, although this differ-
ence was not significant. Additionally in that study,28 
incubation of synovial fluid samples in blood culture 
medium for 24 hours before initiation of culture re-
sulted in bacterial growth from all samples.
The number of joints affected per foal (mean ± 
SD, 2.4 ± 2 joints) in this study was similar to that 
of another study.2 Results of other studies2,9 indicate 
that the joints most commonly affected in foals with 
septic arthritis are the tarsocrural and femorotibial 
joints. In the foals of the present study, the tarsal and 
stifle joints comprised 76 (39%) and 41 (21%), re-
spectively, of the 196 affected joints. In children with 
septic arthritis, the hip joint is the joint most com-
monly affected because of the shared metaphyseal 
and epiphyseal blood supply and the intracapsular 
nature of the femoral metaphysis.19 In the present 
study, only 3 of the 196 (1.5%) affected joints were 
hip joints, a finding that was similar to the results of 
other studies2,7 of foals with septic arthritis in which 
the hip joint represented only 2.3% and 2.6% of the 
affected joints. Differences in the anatomy and skel-
etal maturation may explain the apparent differenc-
es in predilection sites for septic arthritis between 
foals and children. In neonatal foals, blood vessels 
connect the metaphyseal and epiphyseal blood sup-
plies together. However, those vessels generally close 
when foals are between 7 and 10 days old, which 
may explain why the foals in the oldest age group 
(31 to 180 days old) of the present study had fewer 
affected joints than did the foals in the other 2 age 
groups (≤ 7 and 8 to 30 days old). The close proxim-
ity of the physis and metaphysis to the capsule in the 
femorotibial and tarsocrural joints may contribute to 
the frequency with which those joints are infected 
in both foals and human patients. Additionally, the 
large size of these joints, compared with the size of 
the proximal and distal interphalangeal joints, may 
account for the higher frequency of diagnosis be-
cause joint effusion is more easily detected.
Unlike adult horses with septic arthritis, foals 
with septic arthritis frequently have evidence of sub-
stantial systemic inflammation.5 In foals, plasma fi-
brinogen concentrations between 500 and 800 mg/
dL are often associated with septic arthritis and 
nonrhodococcal pneumonia.29 For the foals of the 
present study, the probability of survival to hospital 
discharge was positively associated with plasma fi-
brinogen concentration but was not significantly as-
sociated with peripheral WBC count. Results of mul-
tiple studies15,30,31 have failed to indicate a significant 
association between the likelihood of survival and 
plasma fibrinogen concentration. In studies that in-
volved foals with neonatal sepsis32 and acute colitis,33 
the mean plasma fibrinogen concentration was higher 
for foals that survived, compared with that for foals 
that did not survive, although that difference was not 
significant. Conversely, in another study of critically 
ill foals,34 a fibrinogen concentration increased from 
the basal level was identified as a predictor of death. 
However, in a study35 of human neonates with sepsis, 
mean fibrinogen concentration was higher in survi-
vors than that in nonsurvivors. In the present study, 
mean WBC count, segmented neutrophil count, and 
plasma fibrinogen concentration were significantly 
lower for foals ≤ 7 days old, compared with those for 
the foals in the other 2 age groups, which suggested 
that concurrent systemic disease (ie, sepsis) may be 
more common at younger ages.
Treatment of septic arthritis in neonatal foals 
involves lavage and surgical debridement of the af-
fected synovial structure and systemic and localized 
antimicrobial administration. Selection of an antimi-
crobial for the treatment of foals with septic arthri-
tis should take into account the antimicrobial sus-
ceptibility profile of the causative pathogen as well 
as the potential adverse effects of the drug. Results 
of the antimicrobial susceptibility testing for the 
isolates of the present study suggested that amino-
glycosides (eg, amikacin and gentamicin) and vari-
ous cephalosporins would be reasonable options for 
the empirical treatment of foals with septic arthritis 
presumed to be caused by gram-negative organisms. 
Gram-positive organisms had variable susceptibility 
to commonly administered antimicrobials; 17 of 21 
(81%) gram-positive isolates tested were susceptible 
to trimethoprim-sulfamethoxazole combinations, 
whereas only 14 (67%) were susceptible to ceftiofur. 
Many of the isolates of the present study appeared to 
be susceptible to fluoroquinolones in vitro, including 
ciprofloxacin, enrofloxacin, marbofloxacin, and orbi-
floxacin; however, the detrimental effects of fluoro-
quinolones on developing cartilage should preclude 
their use in foals unless absolutely warranted.36,37 
Susceptibility to cephalosporins varied between 
gram-negative and gram-positive bacteria. Because 
the later (third or later) generations of cephalo-
sporins have an increased gram-negative spectrum, 
compared with that of the first and second genera-
tions of cephalosporins, ceftiofur, cefpodoxime, and 
ceftazidime may be more appropriate choices for 
the empirical treatment of septic arthritis in foals.38 
The limited number of isolates tested for suscepti-
bility against some of the antimicrobials assessed in 
the present study might have skewed the data; thus, 
selection of an antimicrobial for the empirical treat-
ment of foals with septic arthritis solely on the basis 
of these findings is not recommended.
Septic arthritis is the most common cause of lame-
ness in foals and can have devastating consequences, 
which can include death and decreased future athletic 
performance.1,3,5 The survival rate (56.6% [47/83]) for 
the foals of the present study was consistent with those 
(45% to 78%) reported by investigators of other stud-
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ies5,7,21 of foals with septic arthritis. Foals with septic 
arthritis that are treated and survive frequently do not 
achieve their full performance potential, which may 
explain why many foals with septic arthritis are eu-
thanized without attempting aggressive treatment.6 In 
a study6 examining future performance of foals treated 
for septic arthritis, although 58 of 69 (84%) foals with 
septic arthritis survived, only 23 of those foals went on 
to start ≥ 1 race during their lifeline, and foals that sur-
vived septic arthritis were significantly (P = 0.008) less 
likely to start a race than were their unaffected siblings 
(OR, 0.36).
The major limitation of the present study was its 
retrospective nature, which has inherent biases. Some 
medical records were incomplete, which resulted in 
data sets that did not have entries for all study sub-
jects. Foals that did not survive to hospital discharge 
were analyzed together, regardless of the role that fi-
nancial constraints may have had on the decision to 
euthanize versus treat. It is likely that patients with 
a poor prognosis and high estimated treatment costs 
were more likely to be euthanized, thus skewing the 
proportion of foals that survived to discharge. The 
inclusion criteria may have been excessively strin-
gent and limited the number of cases included in the 
study, which could have potentially skewed the data. 
The specific cell populations identified in the synovial 
fluid samples were not analyzed because of inconsis-
tencies in the performance of cytologic analyses. For 
example, foals that had synovial fluid samples with a 
low TNCC, of which a high percentage of cells were 
neutrophils, may have been excluded from the study 
population, despite being considered septic by other 
standards. Because the study population included 
foals treated at 2 facilities, the variables measured and 
culture methodologies varied, which made compari-
sons for some variables difficult. It is possible that ad-
ditional associations might have been identified had a 
larger population been assessed. The number of sub-
jects in this study limited the power to detect signifi-
cant differences between rates of infection with gram-
positive and gram-negative bacteria; a larger study is 
necessary to better elucidate those frequencies.
In the present study, differences and similarities in 
multiple variables were identified among age groups 
for foals with septic arthritis. Although age group (≤ 7, 
8 to 30, and 31 to 180 days old) was not significantly 
associated with the type of bacteria (gram negative or 
gram positive) cultured from the affected joints, gram-
negative bacteria were cultured from the synovial fluid 
of affected joints more frequently than were gram-
positive bacteria, and E coli was the organism most 
commonly isolated from all age groups. The probabil-
ity of survival to discharge did not differ significantly 
among the 3 age groups; however, it was negatively 
associated with the number of joints affected. The 
mean number of joints affected per foal was signifi-
cantly lower for foals in the 31 to 180 days old group, 
compared with that for foals in the other 2 groups. 
Interestingly, the probability of survival to discharge 
from the hospital was positively associated with plas-
ma fibrinogen concentration but not with the other 
hematologic variables and synovial fluid characteris-
tics assessed. To our knowledge, this study is the first 
to indicate a significant positive association between 
the probability of short-term survival and plasma fi-
brinogen concentration in foals with septic arthritis 
and that provided a description of the antimicrobial 
susceptibility results for bacterial isolates commonly 
cultured from the septic joints of foals. This informa-
tion may be helpful during the initial assessment and 
empirical treatment of foals with septic arthritis. 
a. TREK Sensititre, Thermo Scientific, Westlake, Ohio.
b. SAS, version 9.3, SAS Institute Inc, Cary, NC.
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From this month’s AJVR 
Effect of dantrolene premedication  
on various cardiac and biochemical variables  
and the recovery of healthy isoflurane-anesthetized horses
Erica C. McKenzie et al
Objective—To determine the effect of dantrolene premedication on various cardiovascular and 
biochemical variables and the recovery of isoflurane-anesthetized horses.
Animals—6 healthy horses.
Procedures—Each horse was anesthetized twice with a 21- to 28-day washout period between 
anesthetic sessions. Food was not withheld from horses before either session. During each session, 
dantrolene (6 mg/kg in 2 L of water) or water (2 L) was administered via a nasogastric tube 1 hour 
before anesthesia was induced. Anesthesia was maintained with isoflurane for 90 minutes, during 
which blood gas analyses and lithium-dilution cardiac output (CO) measurements were obtained 
every 10 minutes. Serum creatine kinase activity was measured before and at 4, 8, and 12 hours 
after anesthesia.
Results—When horses were premedicated with dantrolene, CO was significantly lower than that 
when horses were premedicated with water at 25, 35, and 45 minutes into anesthesia, after which 
time difficulty in obtaining valid measurements suggested a continued decrease in CO; plasma 
potassium concentration progressively increased during anesthesia, whereas serum creatine kinase 
activity remained fairly stable and within reference limits through 12 hours after anesthesia; and 2 of 
6 horses developed cardiac arrhythmias that required medical intervention. The quality of anesthetic 
recovery was slightly better when horses were premedicated with dantrolene versus water, although 
the time required for recovery did not differ significantly between treatments.
Conclusions and Clinical Relevance—Results suggested that dantrolene premedication prevented 
muscle damage without affecting anesthetic recovery but may impair CO and precipitate hyperkalemia 
and cardiac arrhythmias in healthy isoflurane-anesthetized horses. (Am J Vet Res 2015;76:293–301)
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